Novel Therapeutic Targets for Migraine
Author:
Affiliation:
1. Jefferson Headache Center, Department of Neurology, Thomas Jefferson University, Philadelphia, PA 19107, USA
2. Center for Neurological Restoration, Neurological Institute, Cleveland Clinic, Cleveland, OH 44195, USA
Abstract
Publisher
MDPI AG
Subject
General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)
Link
https://www.mdpi.com/2227-9059/11/2/569/pdf
Reference87 articles.
1. The global prevalence of headache: An update, with analysis of the influences of methodological factors on prevalence estimates;Stovner;J. Headache Pain,2022
2. GBD Diseases Injuries Collaborators (2020). Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet, 396, 1204–1222.
3. CGRP as the target of new migraine therapies—Successful translation from bench to clinic;Edvinsson;Nat. Rev. Neurol.,2018
4. Migraine and the trigeminovascular system-40 years and counting;Ashina;Lancet Neurol.,2019
5. Calcitonin gene-related peptide is a potent vasodilator;Brain;Nature,1985
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Menthol dural application alters meningeal arteries tone and enhances excitability of trigeminocervical neurons in rats;Brain Research;2024-02
2. Towards precision medicine in migraine: Recent therapeutic advances and potential biomarkers to understand heterogeneity and treatment response;Pharmacology & Therapeutics;2023-10
3. Oxybutynin for Primary Palmer Hyperhidrosis Attenuates Migraine Attacks and Burdens;Cureus;2023-09-07
4. Zavegepant: First Approval;Drugs;2023-05-25
5. Emerging drugs for the preventive treatment of migraine: a review of CGRP monoclonal antibodies and gepants trials;Expert Opinion on Emerging Drugs;2023-04-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3